Ocular Therapeutix Inc
NASDAQ:OCUL

Watchlist Manager
Ocular Therapeutix Inc Logo
Ocular Therapeutix Inc
NASDAQ:OCUL
Watchlist
Price: 6.81 USD -7.09%
Market Cap: 1.1B USD

Intrinsic Value

OCUL's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one OCUL stock under the Base Case scenario is 3.99 USD. Compared to the current market price of 6.81 USD, Ocular Therapeutix Inc is Overvalued by 41%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

OCUL Intrinsic Value
3.99 USD
Overvaluation 41%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Ocular Therapeutix Inc

OCUL
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for OCUL cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Ocular Therapeutix Inc
NASDAQ:OCUL
US
Pharmaceuticals
Market Cap
1.1B USD
IPO
Jul 25, 2014
US
Pharmaceuticals
Market Cap
1.1B USD
IPO
Jul 25, 2014
Price
$false
EPS
$false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about OCUL?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Ocular Therapeutix Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Ocular Therapeutix Inc

Current Assets 441m
Cash & Short-Term Investments 392.1m
Receivables 32.4m
Other Current Assets 16.5m
Non-Current Assets 16.9m
PP&E 15.3m
Other Non-Current Assets 1.6m
Efficiency

Free Cash Flow Analysis
Ocular Therapeutix Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Ocular Therapeutix Inc

Revenue
63.7m USD
Cost of Revenue
-5.6m USD
Gross Profit
58.1m USD
Operating Expenses
-229.9m USD
Operating Income
-171.8m USD
Other Expenses
-21.7m USD
Net Income
-193.5m USD
Fundamental Scores

OCUL Profitability Score
Profitability Due Diligence

Ocular Therapeutix Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Positive 3-Years Revenue Growth
Positive 1-Year Revenue Growth
23/100
Profitability
Score

Ocular Therapeutix Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

OCUL Solvency Score
Solvency Due Diligence

Ocular Therapeutix Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
60/100
Solvency
Score

Ocular Therapeutix Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

OCUL Price Targets Summary
Ocular Therapeutix Inc

Wall Street analysts forecast OCUL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OCUL is 17.85 USD with a low forecast of 14.14 USD and a high forecast of 23.1 USD.

Lowest
Price Target
14.14 USD
108% Upside
Average
Price Target
17.85 USD
162% Upside
Highest
Price Target
23.1 USD
239% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Ocular Therapeutix Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for OCUL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

OCUL Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one OCUL stock?

The intrinsic value of one OCUL stock under the Base Case scenario is 3.99 USD.

Is OCUL stock undervalued or overvalued?

Compared to the current market price of 6.81 USD, Ocular Therapeutix Inc is Overvalued by 41%.

Back to Top